8109.0 - Research and Experimental Development, Government and Private Non-Profit Organisations, Australia, 2014-15 Quality Declaration 
Latest ISSUE Released at 11:30 AM (CANBERRA TIME) 06/07/2016   
   Page tools: Print Print Page Print all pages in this productPrint All RSS Feed RSS Bookmark and Share Search this Product

PRIVATE NON-PROFIT EXPENDITURE ON R&D (PNPERD)

TYPE OF EXPENDITURE

In 2014-15, PNPERD included $954 million (95%) in total Current expenditure and $53 million (5%) in total Capital expenditure. The largest component of PNPERD in 2014-15 was Labour costs, at $540 million (54% of PNPERD). This was followed by Other current expenditure, at $423 million (41% of PNPERD) which recorded the largest increase in PNPERD, up $35 million (7%) from 2012-13.

SOURCE OF FUNDS

In 2014-15, Commonwealth government funds was the largest contributing Source of funds to total PNPERD, at $386 million (38% of total PNPERD), followed by Own funds, at $230 million (23% of total PNPERD).

Of all sources of funds, State and local government recorded the largest dollar increase from 2012-13, up $20 million (25%). This was followed by Business funds, up $10 million (20%) in 2014-15. Joint government and business funds recorded the largest dollar decrease, down $5 million (54%) between 2012-13 and 2014-15.

LOCATION OF EXPENDITURE

Location of expenditure relates to the region in which R&D activity was performed; see Explanatory Notes for details.

In 2014-15, Victoria ($486 million) and New South Wales ($331 million) together accounted for 81% of total PNPERD. Victoria, up $38 million (8%) and Queensland, up $13 million (47%) recorded the largest dollar increases in PNPERD from 2012-13. New South Wales recorded the largest dollar decrease, down $22 million (6%) between 2012-13 and 2014-15.

Image: PNPERD, top five locations, 2012-13 and 2014-15.



PNPERD and Gross State Product (GSP)

In 2014-15, PNPERD as a proportion of Gross State Product (GSP) was highest for Victoria at 0.13%.

PNPERD, by location of expenditure - proportion of GSP(a)

NSW
Vic.
Qld
SA
WA
Tas.
NT
ACT
%
%
%
%
%
%
%
%

2012-13
0.07
0.13
0.01
0.03
0.03
np
0.05
0.01
2014-15
0.06
0.13
0.01
0.03
0.03
-
0.03
0.02

- nil or rounded to zero (including null cells)
np not available for publication but included in totals where applicable, unless otherwise indicated.
(a) See Explanatory Notes for details.

TYPE OF ACTIVITY

In 2014-15, over two thirds (70%) of PNPERD was directed towards Strategic basic research, at $361 million (36% of total PNPERD) and Applied research, at $347 million (35% of total PNPERD). The remaining expenditure was directed towards Experimental development, at $218 million (22%) and Pure basic research, at $81 million (8%).

Compared to 2012-13, Strategic basic research recorded the largest dollar increase, up $27 million (8%). Pure basic research recorded the largest dollar and percentage decrease down $7 million or 8% from 2012-13. The distribution of PNPERD across Type of activity remained largely unchanged in 2014-15.


FIELDS OF RESEARCH (FOR)

Medical and Health Sciences ($788 million) remained the largest Field of Research for PNP organisations in 2014-15, accounting for more than three quarters (78%) of total PNPERD. The next largest Field of Research was Biological Sciences, which accounted for $57 million (6% of total PNPERD).

The largest dollar increase in PNPERD in 2014-15 was recorded by Medical and Health Sciences, up $38 million (5%). The largest dollar decrease in PNPERD was recorded by Biological Sciences, down $19 million (25%).


SOCIO-ECONOMIC OBJECTIVE (SEO)

The majority of PNPERD (85%) was directed to the Socio-economic Objective of Health ($859 million) in 2014-15. Education and Training was the next largest Socio-economic Objective, with $65 million (7% of total PNPERD).

Health, up $35 million (4%) and Education and Training, up $9 million (16%) also recorded the largest dollar increases among Socio-economic Objectives between 2012-13 and 2014-15. Law, Politics and Community Services recorded the largest dollar decrease, down $3 million (45%).